Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer's; Leqembi IQLIK, a subcutaneous version of Leqembi, will launch on Oct. 6, 2025, with a list price of $375 per autoinjector.

Media coverage

• Title	Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer's; Leqembi IQLIK, a subcutaneous version of Leqembi, will launch on Oct. 6, 2025, with a list price of $375 per autoinjector.
  Media name/outlet	Managed Healthcare Executive (MJH)
  Country/Territory	United States
  Date	1/09/25
  Persons	Howard Fillit